Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gene Therapy

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301461PMID 11423930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Size-dependent DNA Mobility in Cytoplasm and Nucleus*

  2000cited by this paper
• Gene Chemistry: Functionally and Conformationally Intact Fluorescent Plasmid DNA

  1999cited by this paper
• Physicochemical characterization and purification of cationic lipoplexes.

  1999cited by this paper
• Intratracheal Administration of Interleukin 12 Plasmid-Cationic Lipid Complexes Inhibits Murine Lung Metastases

  1999cited by this paper
• Intracellular Accumulation of Secreted Proteoglycans Inhibits Cationic Lipid-mediated Gene Transfer

  1999cited by this paper
• Lipoplex-Mediated Gene Delivery to the Lung Occurs within 60 Minutes of Intravenous Administration

  1999cited by this paper
• Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection

  1999cited by this paper
• Characterization and In Vivo Testing of a Heterogeneous Cationic Lipid-DNA Formulation

  1998cited by this paper
• Aerosol Delivery of Lipid:DNA Complexes to Lungs of Rhesus Monkeys

  1998cited by this paper
• Proteoglycans Mediate Cationic Liposome-DNA Complex-based Gene Delivery in Vitro and in Vivo *

  1998cited by this paper
• Target Specific Optimization of Cationic Lipid-Based Systems for Pulmonary Gene Therapy

  1998cited by this paper
• Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic Administration

  1998cited by this paper
• Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapy

  1998cited by this paper
• Effects of Complement Depletion on the Pharmacokinetics and Gene Delivery Mediated by Cationic Lipid–DNA Complexes

  1998cited by this paper
• Optimization of Formulations and Conditions for the Aerosol Delivery of Functional Cationic Lipid:DNA Complexes

  1997cited by this paper
• Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo.

  1997cited by this paper
• Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice.

  1997cited by this paper
• Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC

  1997cited by this paper
• Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

  1997cited by this paper
• In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes

  1997cited by this paper
• In Vivo Gene Transfer by Intravenous Administration of Stable Cationic Lipid/DNA Complex

  1997cited by this paper
• On the mechanism of DNA transfection: efficient gene transfer without viruses

  1997cited by this paper
• Basis of Pulmonary Toxicity Associated with Cationic Lipid-Mediated Gene Transfer to the Mammalian Lung

  1997cited by this paper
• Nomenclature for Synthetic Gene Delivery Systems

  1997cited by this paper
• Improved DNA: liposome complexes for increased systemic delivery and gene expression

  1997cited by this paper
• A Concentrated and Stable Aerosol Formulation of Cationic Lipid:DNA Complexes Giving High-Level Gene Expression in Mouse Lung

  1997cited by this paper
• Evidence for the role of proteoglycans in cation-mediated gene transfer.

  1996cited by this paper
• Mechanism of oligonucleotide release from cationic liposomes.

  1996cited by this paper
• Parameters influencing the introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system.

  1995cited by this paper
• Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics.

  1995cited by this paper
• Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.

  1995cited by this paper
• Systemic gene expression after intravenous DNA delivery into adult mice.

  1993cited by this paper
• Aerosol gene delivery in vivo.

  1992cited by this paper
• Rapid nuclear accumulation of injected oligodeoxyribonucleotides.

  1990cited by this paper
• Rapid CommunicationRapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene using a Liposome Vehicle

  1989cited by this paper
• Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection.

  1986cited by this paper
• The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker.

  1982cited by this paper
• Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation.

  1976cited by this paper

• Multiplexed spatial screening of extrahepatic lipid-based nanoparticles for in vivo messenger RNA targeting.

  2026cites this paper
• Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug.

  2025cites this paper
• The replacement of helper lipids with charged alternatives in lipid nanoparticles facilities targeted mRNA delivery to the spleen and lungs.

  2022cites this paper
• P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation.

  2021cites this paper
• Lipoplex-based therapeutics for effective oligonucleotide delivery: a compendious review

  2020cites this paper
• Therapeutic siRNA: state of the art

  2020cites this paper
• Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome

  2020cites this paper
• Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy

  2019cites this paper
• Lipid-coated Magnesium Phosphate Nanoparticles for Intrapulmonary Protein Delivery in Mice

  2019cites this paper
• Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.

  2018cites this paper
• Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice.

  2018cites this paper
• miRNAs in Alzheimer Disease - A Therapeutic Perspective.

  2017cites this paper
• The Chemistry of Oligonucleotide Delivery

  2017cites this paper
• Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.

  2017cites this paper
• Lipoplexes in Gene Therapy Under the Considerations of Scaling Up, Stability Issues, and Pharmaceutical Requirements

  2016cites this paper
• Nanomaterials as Therapeutic/Imaging Agent Delivery Vehicles for Tumor Targeting Theranostics

  2016cites this paper
• Therapeutic face of RNAi: in vivo challenges

  2015cites this paper
• microRNAs and Neurodegenerative Diseases.

  2015cites this paper
• Pharmaceutical applications of Confocal Laser Scanning Microscopy

  2014cites this paper
• Neutralized Nanoparticle Composed of SS‐Cleavable and pH‐Activated Lipid‐Like Material as a Long‐Lasting and Liver‐Specific Gene Delivery System

  2014cites this paper
• The involvement of microRNAs in neurodegenerative diseases

  2013cites this paper
• An investigation into the role of pericytes in regulation of vascular morphology and function using murine models of inflammation

  2013cites this paper
• Delivery Systems for Pulmonary Gene Therapy

  2012cites this paper
• In vivo delivery aspects of miRNA, shRNA and siRNA.

  2012cites this paper
• Asymmetric 1-alkyl-2-acyl phosphatidylcholine: a helper lipid for enhanced non-viral gene delivery.

  2012cites this paper
• Antisense Oligonucleotides and RNA Interference

  2011cites this paper
• Gene Therapy with Plasmid DNA

  2010cites this paper
• Functional Delivery of siRNA in Mice Using Dendriworms

  2009cites this paper
• Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics.

  2009cites this paper
• Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery

  2009cites this paper
• An efficient liposomal gene delivery vehicle using Sendai F/HN proteins and protamine

  2008cites this paper
• Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex.

  2007cites this paper
• Identification of transfected cell types following non‐viral gene transfer to the murine lung

  2007cites this paper
• Unsaturated cationic ortho esters for endosome permeation in gene delivery.

  2007cites this paper
• Unilateral lung-selective gene transfer following the administration of naked plasmid DNA onto the pulmonary pleural surface in mice.

  2007cites this paper
• Effect of the particle size of galactosylated lipoplex on hepatocyte-selective gene transfection after intraportal administration.

  2006cites this paper
• Widespread lipoplex‐mediated gene transfer to vascular endothelial cells and hemangioblasts in the vertebrate embryo

  2006cites this paper
• In vivo electroporation and ubiquitin promoter – a protocol for sustained gene expression in the lung

  2006cites this paper
• Pulmonary delivery of insulin by liposomal carriers.

  2006cites this paper
• In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate).

  2006cites this paper
• Vector System: Plasmid DNA

  2006cites this paper
• Positively-Charged Liposomes for Targeting Tumor Vasculature

  2006cites this paper
• Pharmacokinetics of Nanocarrier-Mediated Drug and Gene Delivery

  2006cites this paper
• Les copolymères à blocs pour le transfert de gènes dans le muscle squelettique

  2006cites this paper
• Calcium enhances the transfection potency of stabilized plasmid-lipid particles.

  2005cites this paper
• Lipid Mixing between Lipoplexes and Plasma Lipoproteins Is a Major Barrier for Intravenous Transfection Mediated by Cationic Lipids*

  2005cites this paper
• Confocal-microscopy Studies of a Model Oligoribonucleotide HIV Inhibitor

  2005cites this paper
• Strategies for DNA vaccine delivery

  2005cites this paper
• Toxicity of cationic lipid-DNA complexes.

  2005cites this paper
• Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating.

  2005cites this paper
• Pluronic Block Copolymers for Gene Delivery.

  2005cites this paper
• Toxicity of Cationic Lipid-DNA Complexes.

  2005cites this paper
• Fluorescent lipopolyamines in non-viral gene therapy.

  2005cites this paper
• In Vivo Gene Transfer by Ligand-Modified Gene Carriers

  2005cites this paper
• Gene transfer of the Na+,K+-ATPase beta1 subunit using electroporation increases lung liquid clearance.

  2005cites this paper
• Fluorescence techniques in non-viral gene therapy

  2005cites this paper
• Formation and intracellular trafficking of lipoplexes and polyplexes.

  2005cites this paper
• Non-invasive pulmonary aerosol delivery in mice by the endotracheal route.

  2005cites this paper
• Polymer genomics: shifting the gene and drug delivery paradigms.

  2005cites this paper
• Pluronic block copolymers for gene delivery.

  2005cites this paper
• Non-viral gene delivery to the lungs.

  2005cites this paper
• Cell-Specific Targeting of Lipid-Based Carriers for ODN and DNA

  2005cites this paper
• Nanoparticle-mediated gene delivery: state of the art

  2004cites this paper
• Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection

  2004cites this paper
• Development of Nonviral DNA Delivery Systems

  2004cites this paper
• Enhanced intravenous transgene expression in mouse lung using cyclic-head cationic lipids.

  2004cites this paper
• Endocrine aspects of cancer gene therapy.

  2004cites this paper
• DOTAP (and other cationic lipids): chemistry, biophysics, and transfection.

  2004cites this paper
• 12 Fluorescence Techniques in Non-Viral Gene Therapy

  2004cites this paper
• Electroporation as a method for high-level nonviral gene transfer to the lung

  2003cites this paper
• Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature.

  2003cites this paper
• Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: implications for intravenous gene transfer.

  2003cites this paper
• Plasmid DNA–Mediated Gene Therapy

  2003cites this paper
• Biodistribution study of phosphonolipids: a class of non‐viral vectors efficient in mice lung‐directed gene transfer

  2003cites this paper
• Expression of thymidine kinase driven by an endothelial-specific promoter inhibits tumor growth of Lewis lung carcinoma cells in transgenic mice

  2003cites this paper
• CATIONIC LIPID-NUCLEIC ACID COMPLEXES (LIPOPLEXES): FROM PHYSICOCHEMICAL PROPERTIES TO IN VITRO AND IN VIVO TRANSFECTION KITS

  2003cites this paper
• Targeting of Synthetic Gene Delivery Systems

  2003cites this paper
• Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises.

  2003cites this paper
• Electroporation of the Vasculature and the Lung

  2003cites this paper
• Mechanisms for Cationic Lipids in Gene Transfer

  2003cites this paper
• In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy

  2002cites this paper
• Cytotoxicity issues pertinent to lipoplex‐mediated gene therapy in‐vivo

  2002cites this paper
• Factors affecting drug and gene delivery: effects of interaction with blood components.

  2002cites this paper
• Cationic Lipids for Lung Gene Therapy

  2002cites this paper
• Visualization of the transgene distribution according to the administration route allows prediction of the transfection efficacy and validation of the results obtained

  2002cites this paper
• Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.

  2002cites this paper
• Robust and prolonged gene expression from injectable polymeric implants

  2002cites this paper
• Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy.

  2002cites this paper
• Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation.

  2002cites this paper
• Recent developments in cationic lipid-mediated gene delivery and gene therapy

  2001cites this paper